For many women, waking up with a persistent headache, battling jittery anxiety, or struggling to keep their eyes open at the office despite a full night in bed is chalked up to the demands of daily life. The potential culprits often cited are menstruation, menopause, or motherhood—a seemingly endless loop of common physiological milestones. However, these vague and disruptive symptoms frequently point toward a heavily misunderstood health condition historically sidelined as a "male disease": obstructive sleep apnea, or OSA.
When most people picture someone with obstructive sleep apnea, the mental image is typically that of an older man dozing on a couch and snoring loudly. This stereotype is deeply entrenched, and for good reason. It was not until the 1990s that medical researchers first recognized that OSA, a disorder characterized by the repeated cessation of breathing during sleep, often presents entirely differently in women than it does in men. Most notably, many women suffering from the condition do not snore at all, entirely bypassing the hallmark sign that triggers clinical suspicion.
While there is still much to discover regarding the biology underlying these distinct clinical presentations, ongoing research suggests that hormonal fluctuations across a woman’s lifespan, anatomical differences in the upper airway, and even social stigmas surrounding how women are expected to sleep play significant roles.
"The disease itself was defined in men," explains Jennifer Martin, PhD, a behavioral sleep medicine specialist and professor at Florida International University’s Herbert Wertheim College of Medicine in Miami. "The way men and women breathe when they’re asleep is not the same, and our definition of the disease doesn’t account for that."
Although obstructive sleep apnea appears to be statistically less common and typically milder in women prior to menopause, emerging studies indicate that the long-term consequences of the untreated disease can be just as severe—if not worse—for female patients. Recognizing the warning signs and navigating the healthcare system for proper care remains a critical hurdle for millions of women.
How and Why Sleep Apnea Differs in Women
Sleep apnea belongs to a broader category of conditions known as sleep-disordered breathing. The most prevalent form is OSA, which occurs when the upper airway repeatedly collapses during sleep, obstructing the free flow of air to the lungs, according to Anita Valanju Shelgikar, MD, a sleep medicine physician with University of Michigan Health and president of the American Academy of Sleep Medicine.
The textbook symptoms of this condition—benchmarks established largely through studies involving male participants—include loud snoring and dramatic, sudden gasps for air as the individual struggles to resume breathing mid-slumber. However, Dr. Shelgikar notes that this clinical picture rarely matches the reality for female patients. Instead, women with OSA are far more likely to experience nightmares, frequent nocturnal awakenings, difficulties maintaining sleep, and stubborn insomnia. These disruptions subsequently manifest during waking hours as severe daytime fatigue, morning headaches, and volatile mood swings. Furthermore, women tend to experience more hypopneas, which are characterized by shallow breaths and reduced oxygen flow, whereas men are more prone to classic apneas, defined as complete pauses in breathing.
Some medical experts speculate that the lower rate of reported snoring among women may partly stem from social embarrassment, as societal expectations often discourage women from acknowledging noisy sleep habits. Yet, a growing body of biological research offers a more concrete explanation for these sex-related differences. Compared to men, women generally possess smaller, structurally more stable airways that are less prone to collapsing and vibrating during sleep. Additionally, women typically carry less adipose tissue around their necks, and premenopausal women benefit from the protective physiological effects of estrogen and progesterone, which interact beneficially with the respiratory system to support stable breathing.
These physiological factors help explain why more men than women in the United States currently carry a diagnosis, comprising roughly 59% and 41% of obstructive sleep apnea patients, respectively. The landscape shifts dramatically, however, once women undergo menopause. As estrogen and progesterone levels decline, the prevalence of OSA and the severity of its symptoms increase sharply, notes Dr. Martin. Studies indicate that between 47% and 67% of postmenopausal women suffer from obstructive sleep apnea, a prevalence rate that parallels or even exceeds that of men in the same age demographic of 50 and older. Despite these high numbers, the proportion of women receiving an actual clinical diagnosis remains disproportionately low.
Regardless of age, women continue to report a greater burden of sleep apnea-related symptoms than men, even when presenting with a milder form of the condition. This disparity arises because women experience more subtle, frequent breathing disturbances throughout the night that cumulatively degrade the overall restorative quality of their rest.
Why Misdiagnoses Are Common in Women With Sleep Apnea
Because women frequently fail to exhibit the classic clinical markers of OSA, they are highly susceptible to having their symptoms misdiagnosed or outright dismissed by healthcare providers.
"When men walk into a physician’s office and say they’re sleepy and they snore, they get a diagnostic test right away," Dr. Martin observes. "When a woman walks in and says, ‘I don’t sleep well, and I’m very fatigued during the day,’ they don’t often get referred" for formal screening. Research bears this out, suggesting that men are roughly nine times more likely to be referred for diagnostic testing than women experiencing similar fatigue levels.
Women presenting with OSA symptoms are frequently misdiagnosed with conditions such as depression, anxiety, insomnia, or menopausal transition, or their complaints are attributed to medication side effects, explains Dr. Shelgikar, who also serves as a neurology professor at the University of Michigan Medical School. Compounding the issue, women frequently suffer from these co-occurring conditions simultaneously, which can both obscure the underlying sleep apnea and worsen its severity. Consider the intersection of insomnia and OSA: having both disorders concurrently is more common among women than men, according to Dr. Martin. In some cases, these patients may be prescribed sleep aids—such as diphenhydramine or benzodiazepines—that further relax throat muscles, exacerbating the airway collapse and leaving the patient even more oxygen-deprived.
Diagnostic criteria themselves remain heavily skewed toward male physiology. "When we diagnose sleep apnea, we require one of two things to happen: A breathing interruption has to be associated either with a drop in oxygen levels or a brief awakening from sleep," Dr. Martin says. "Women don’t have those very deep drops in oxygen levels that men do. So that means that the way we define the disease itself kind of biases us towards diagnosing it more in men than women."
Furthermore, insurance structures like Medicare, upon which the vast majority of Americans aged 65 and older rely, historically recognize a sleep apnea diagnosis only when a patient demonstrates steep, measurable drops in blood oxygen levels during testing. Mid-slumber micro-awakenings alone often fail to satisfy these rigid benchmarks, meaning the baseline criteria enforced by major payers remain decidedly male-centric.
At-home sleep apnea tests, which are increasingly utilized as a more affordable and convenient alternative to comprehensive in-lab polysomnography, are similarly prone to missing the condition in female patients. Because women tend to exhibit fewer and milder observable respiratory events, portable home monitors often lack the sensitivity required to capture the disorder accurately within this population. The margin for error widens further in women struggling with insomnia. Individuals who experience fragmented sleep may fail to log enough total sleep time during an overnight monitoring session to yield an accurate evaluation, resulting in false negatives that underestimate the true severity of their condition.
This diagnostic gap indicates that sleep apnea is likely far more prevalent among women than current health statistics reflect. Consequently, a vast number of female patients are going without essential medical intervention, allowing a manageable condition to cascade into a series of preventable health complications.
Why You Should Treat Your Sleep Apnea
Leaving obstructive sleep apnea untreated carries profound long-term consequences, particularly for cardiovascular health, explains Atul Malhotra, MD, research chief of pulmonary, critical care, and sleep medicine at UC San Diego Health. Each time an airway collapses, the resulting oxygen deficit prompts the body to release adrenaline, a stress hormone designed to jolt the individual awake just enough to resume breathing. These micro-arousals happen rapidly, usually lasting only a few seconds, leaving the patient with no conscious memory of the event the following morning.
Over time, this repeated nocturnal stress places immense strain on the cardiovascular system, elevating the risk of hypertension, myocardial infarction, stroke, cardiac arrhythmias, and heart failure. Although clinical evidence remains nuanced, some studies suggest that women with severe sleep apnea may be particularly vulnerable to cardiovascular complications. Furthermore, female patients frequently present with a higher burden of comorbid conditions at the time of an OSA diagnosis, including thyroid disorders, asthma, and clinical depression. While this raises complex questions regarding causal direction, treating underlying sleep-disordered breathing consistently yields positive health benefits.
Because OSA severely degrades sleep architecture, it is directly linked to cognitive deficits, memory lapses, and reduced daytime alertness, which in turn increase the risk of motor vehicle collisions and workplace errors, particularly in safety-sensitive industries. Less frequently discussed is the toll that untreated sleep apnea takes on emotional well-being, daily functioning, and interpersonal relationships.
"We don’t do a good job thinking about sleep apnea as a potential cause of mental health symptoms," Dr. Martin notes. Clinical data demonstrates that properly managing and treating OSA can significantly alleviate concurrent symptoms of anxiety and depression for many patients.
As the medical community continues to investigate these sex-based disparities, experts emphasize an encouraging reality: clinical evidence demonstrates that women benefit at least as much as men—if not more—from consistent sleep apnea treatment, making early recognition and advocacy essential for long-term health and well-being.
